Trials / Completed
CompletedNCT01398332
Evaluation of the GORE® C3 Delivery System Module
Global Registry for Endovascular Aortic Treatment (GREAT)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 399 (actual)
- Sponsor
- W.L.Gore & Associates · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is an observational Registry designed to obtain early data on the use of the GORE® EXCLUDER® AAA Endoprosthesis with C3 Delivery System.
Detailed description
This is a retrospective and prospective observational cohort Registry designed to obtain data on the use of the GORE® EXCLUDER® AAA Endoprosthesis with C3 Delivery System. Patient and device performance outcomes will be collected during treatment and throughout all post-treatment visits, including follow-up extending up to 10 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Stent graft (EXCLUDER) | Endovascular repair |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2024-07-01
- Completion
- 2024-07-01
- First posted
- 2011-07-20
- Last updated
- 2024-08-01
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01398332. Inclusion in this directory is not an endorsement.